Matthieu DUBAN

Dr. Matthieu DUBAN

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MDMatthieu DUBAN
Matthieu DUBAN
Stéphane CociancichStéphane Cociancich
Stéphane Cociancich
valerie Leclèrevalerie Leclère
valerie Leclère
Nonribosomal peptides are microbial secondary metabolites exhibiting a tremendous structural diversity and a broad range of biological activities useful in the medical and agro-ecological fields. They are built up by huge multimodular enzymes called nonribosomal peptide synthetases. These synthetases are organized in modules constituted of adenylation, thiolation, and condensation core domains. As such, each module governs, according to the collinearity rule, the incorporation of a monomer within the growing peptide. The release of the peptide from the assembly chain is finally performed by a terminal core thioesterase domain. Secondary domains with modifying catalytic activities such as epimerization or methylation are sometimes included in the assembly lines as supplementary domains. This assembly line structure is analyzed by bioinformatics tools to predict the sequence and structure of the final peptides according to the sequence of the corresponding synthetases. However, a constantly expanding literature unravels new examples of nonribosomal synthetases exhibiting very rare domains and noncanonical organizations of domains and modules, leading to several amazing strategies developed by microorganisms to synthesize nonribosomal peptides. In this review, through several examples, we aim at highlighting these noncanonical pathways in order for the readers to perceive their complexity.

17 November 2019 in Molecules
Verified
Journal Article
Open access
PDF file
OOOlumide Omoboye
Olumide Omoboye
NGNiels Geudens
Niels Geudens
MDMatthieu DUBAN
Matthieu DUBAN
MCMickaël Chevalier
Mickaël Chevalier
CFChristophe FLAHAUT
Christophe FLAHAUT
MHMonica Höfte
Monica Höfte
Pseudomonas species are metabolically robust, with capacity to produce secondary metabolites including cyclic lipopeptides (CLPs). Herein we conducted a chemical analysis of a crude CLP extract from the cocoyam rhizosphere-derived biocontrol strain Pseudomonas sp. COW3. We performed in silico analyses on its whole genome, and conducted in vitro antagonistic assay using the strain and purified CLPs. Via LC-MS and NMR, we elucidated the structures of four novel members of the bananamide group, named bananamides D-G. Besides variability in fatty acid length, bananamides D-G differ from previously described bananamides A-C and MD-0066 by the presence of a serine and aspartic acid at position 6 and 2, respectively. In addition, bananamide G has valine instead of isoleucine at position 8. Kendrick mass defect (KMD) allowed the assignment of molecular formulae to bananamides D and E. We unraveled a non-ribosomal peptide synthetase cluster banA, banB and banC which encodes the novel bananamide derivatives. Furthermore, COW3 displayed antagonistic activity and mycophagy against Pythium myriotylum, while it mainly showed mycophagy on Pyricularia oryzae. Purified bananamides D-G inhibited the growth of P. myriotylum and P. oryzae and caused hyphal distortion. Our study shows the complementarity of chemical analyses and genome mining in the discovery and elucidation of novel CLPs. In addition, structurally diverse bananamides differ in their antimicrobial activity.

19 January 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
YMYuka Munakata
Yuka Munakata
Egon HEUSONEgon HEUSON
Egon HEUSON
TDThéo Daboudet
Théo Daboudet
BDBarbara Deracinois
Barbara Deracinois
MDMatthieu DUBAN
Matthieu DUBAN
SSSophie Slezack-Deschaumes
Sophie Slezack-Deschaumes
The exploration of certain microbial resources such as beneficial endophytic microorganisms is considered a promising strategy for the discovery of new antimicrobial compounds for the pharmaceutical industries and agriculture. Thirty-one endophytic bacterial strains affiliated with Bacillus, Janthinobacterium, Yokenella, Enterobacter, Pseudomonas, Serratia, and Microbacterium were previously isolated from vetiver (Chrysopogon zizanioides (L.) Roberty) roots. These endophytes showed antifungal activity against Fusarium graminearum and could be a source of antimicrobial metabolites. In this study, in particular, using high-throughput screening, we analyzed their antagonistic activities and those of their cell-free culture supernatants against three species of Fusarium plant pathogens, a bacterial strain of Escherichia coli, and a yeast strain of Saccharomyces cerevisiae, as well as their capacity to produce lipopeptides. The results showed that the culture supernatants of four strains close to B. subtilis species exhibited antimicrobial activities against Fusarium species and E. coli. Using mass spectrometry analyses, we identified two groups of lipopeptides (surfactins and plipastatins) in their culture supernatants. Whole-genome sequencing confirmed that these bacteria possess NRPS gene clusters for surfactin and plipastatin. In vitro tests confirmed the inhibitory effect of plipastatin alone or in combination with surfactin against the three Fusarium species.

15 May 2023 in Scientific African
Verified
Journal Article
Open access
BWBlaise Waongo
Blaise Waongo
MPMaude Pupin
Maude Pupin
MDMatthieu DUBAN
Matthieu DUBAN
GCGabrielle Chataigne
Gabrielle Chataigne
OZOumarou Zongo
Oumarou Zongo
valerie Leclèrevalerie Leclère
valerie Leclère

21 May 2022 in Gene
Verified
Journal Article
Closed access
RLRabia LADJOUZI
Rabia LADJOUZI
MDMatthieu DUBAN
Matthieu DUBAN
ALAnca Lucau-Danila
Anca Lucau-Danila
DDDjamel Drider
Djamel Drider